Söndag 27 April | 11:36:21 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2025-11-07 08:30 Kvartalsrapport 2025-Q3
2025-08-27 08:30 Kvartalsrapport 2025-Q2
2025-05-20 N/A X-dag ordinarie utdelning SEZI 0.00 SEK
2025-05-19 N/A Årsstämma
2025-04-22 - Kvartalsrapport 2025-Q1
2025-02-17 - Bokslutskommuniké 2024
2024-11-06 - Kvartalsrapport 2024-Q3
2024-10-23 - Extra Bolagsstämma 2024
2024-08-26 - Kvartalsrapport 2024-Q2
2024-05-17 - X-dag ordinarie utdelning SEZI 0.00 SEK
2024-05-16 - Årsstämma
2024-05-07 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-11-28 - Extra Bolagsstämma 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-08-24 - Kvartalsrapport 2023-Q2
2023-05-17 - X-dag ordinarie utdelning SEZI 0.00 SEK
2023-05-16 - Årsstämma
2023-04-28 - Kvartalsrapport 2023-Q1
2023-02-20 - Bokslutskommuniké 2022
2023-02-16 - Extra Bolagsstämma 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-07-15 - Kvartalsrapport 2022-Q2
2022-05-19 - X-dag ordinarie utdelning SEZI 0.00 SEK
2022-05-18 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-12 - Kvartalsrapport 2021-Q3
2021-08-27 - Kvartalsrapport 2021-Q2
2021-05-12 - X-dag ordinarie utdelning SEZI 0.00 SEK
2021-05-11 - Årsstämma
2021-05-06 - Kvartalsrapport 2021-Q1
2021-03-05 - Extra Bolagsstämma 2021
2021-02-26 - Bokslutskommuniké 2020
2020-11-06 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-07-02 - Extra Bolagsstämma 2020
2020-05-15 - X-dag ordinarie utdelning SEZI 0.00 SEK
2020-05-14 - Årsstämma
2020-05-08 - Kvartalsrapport 2020-Q1
2020-02-14 - Bokslutskommuniké 2019
2019-11-08 - Kvartalsrapport 2019-Q3
2019-08-22 - Kvartalsrapport 2019-Q2
2019-08-21 - Extra Bolagsstämma 2019
2019-05-09 - X-dag ordinarie utdelning SEZI 0.00 SEK
2019-05-08 - Årsstämma
2019-05-08 - Kvartalsrapport 2019-Q1
2019-02-15 - Bokslutskommuniké 2018
2018-11-08 - Kvartalsrapport 2018-Q3
2018-08-22 - Kvartalsrapport 2018-Q2
2018-05-09 - X-dag ordinarie utdelning SEZI 0.00 SEK
2018-05-08 - Årsstämma
2018-05-08 - Kvartalsrapport 2018-Q1
2018-03-05 - Extra Bolagsstämma 2018
2018-02-16 - Bokslutskommuniké 2017
2017-11-28 - Kvartalsrapport 2017-Q3
2017-09-15 - Extra Bolagsstämma 2017
2017-08-31 - Kvartalsrapport 2017-Q2
2017-05-23 - Årsstämma
2017-05-23 - Kvartalsrapport 2017-Q1
2017-02-16 - Bokslutskommuniké 2016
2016-11-22 - Kvartalsrapport 2016-Q3
2016-08-31 - Kvartalsrapport 2016-Q2
2016-05-17 - Extra Bolagsstämma 2016
2016-04-28 - X-dag ordinarie utdelning SEZI 0.00 SEK
2016-04-27 - Årsstämma
2016-04-27 - Kvartalsrapport 2016-Q1
2016-02-18 - Bokslutskommuniké 2015
2015-11-24 - Kvartalsrapport 2015-Q3
2015-08-26 - Kvartalsrapport 2015-Q2
2015-05-20 - X-dag ordinarie utdelning SEZI 0.00 SEK
2015-05-19 - Årsstämma
2015-05-19 - Kvartalsrapport 2015-Q1
2015-02-25 - Bokslutskommuniké 2014
2014-11-27 - Kvartalsrapport 2014-Q3
2014-11-21 - Extra Bolagsstämma 2014
2014-08-21 - Kvartalsrapport 2014-Q2
2014-05-15 - X-dag ordinarie utdelning SEZI 0.00 SEK
2014-05-14 - Årsstämma
2014-05-14 - Kvartalsrapport 2014-Q1
2014-02-24 - Bokslutskommuniké 2013
2013-11-27 - Kvartalsrapport 2013-Q3
2013-08-20 - Kvartalsrapport 2013-Q2
2013-05-16 - X-dag ordinarie utdelning SEZI 0.00 SEK
2013-05-15 - Årsstämma
2013-05-15 - Kvartalsrapport 2013-Q1
2013-02-28 - Bokslutskommuniké 2012
2013-01-08 - Extra Bolagsstämma 2013
2012-11-21 - Kvartalsrapport 2012-Q3
2012-08-21 - Kvartalsrapport 2012-Q2
2012-05-24 - X-dag ordinarie utdelning SEZI 0.00 SEK
2012-05-23 - Årsstämma
2012-05-23 - Kvartalsrapport 2012-Q1
2012-02-22 - Bokslutskommuniké 2011
2011-11-23 - Kvartalsrapport 2011-Q3
2011-08-23 - Kvartalsrapport 2011-Q2
2011-05-27 - X-dag ordinarie utdelning SEZI 0.00 SEK
2011-05-26 - Årsstämma
2011-05-26 - Kvartalsrapport 2011-Q1
2011-02-16 - Bokslutskommuniké 2010
2010-11-24 - Kvartalsrapport 2010-Q3
2010-05-28 - X-dag ordinarie utdelning SEZI 0.00 SEK
2010-05-27 - Kvartalsrapport 2010-Q1
2009-11-25 - Kvartalsrapport 2009-Q3

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Senzime är verksamt inom medicinteknikbranschen och fokuserar på utveckling och tillverkning av system för övervakning och diagnostik inom sjukvården. I portföljen ingår system som används för att automatisera och mäta ämnena glukos och laktat i blod och vävnader. Bolagets produkter riktar sig till sjukvårdsinstitutioner och läkare. Verksamheten är global. Senzime grundades 1999 och har sitt huvudkontor i Uppsala.
2023-08-24 07:30:00

Press release: Uppsala, 24 August 2023. Senzime AB:s (publ) interim report for January – June 2023 is now available on the company's website www.senzime.com.

Financial information April – June 2023

  • Net sales amounted to TSEK 8,462 (3,403), an increase of 149 percent. Sales of instruments/others were TSEK 4,072 (2,124), an increase of 92 percent. Sales of disposables were TSEK 4,390 (1,279) an increase of 243 percent.
  • The gross margin excluding amortization was 70.0 percent (50.0).
  • Operating expenses were TSEK 37,101 (40,035).
  • EBITDA was TSEK -30,201 (-38,018).
  • Profit (loss) after financial items was KSEK -35,264 (-40,886).
  • Earnings per share were -0.42 SEK (-0.63).
  • Cash and cash equivalents as of June 30, 2023, were TSEK 41,635 (126,495)

Financial information January – June 2023

  • Net sales amounted to TSEK 15,750 (5,764), an increase of 173 percent Sales of instruments/others were TSEK 7,515 KSEK (3,881), an increase of 94 percent. Sales of disposables were KSEK 8,234 KSEK (1,883), an increase of 337 percent.
  • The gross margin excluding amortization was 69.3 percent (54.6).
  • Operating expenses were TSEK 69,479 (59,927)
  • EBITDA was TSEK -56,661 (-56,168).
  • Profit (loss) after financial items was TSEK -66,955 (-61,866).
  • Earnings per share were -0.84 SEK (-0.96).

Extract from the CEO comment:

Quadrupled growth in sensor sales

It has been an eventful quarter for Senzime. We continue to report strong growth and net sales increased by 149 percent to SEK 8.5 million. Net sales during the first half of the year amounted to SEK 15.8 million, an increase of 173 percent.

Sales of disposable sensors have now more than quadrupled this year as compared to the same period last year, an important signal that the utilization of the TetraGraph systems in the market are gradually increasing. The gross margin before depreciation increased to 70 percent, compared to 50 percent the previous year. This is the result of product mix, licensing income and an efficient production process.

The important US business continues to develop well with sales this year more than three times higher than last year. We have a new commercial leadership in the US and are expanding the organization to meet demand. After the end of the quarter, we won another important deal in the US for 70 TetraGraph systems from a leading university hospital after an extensive competitive evaluation process. The deal reflects well the type of hospital deals we now encounter in the market.

This press release only contains parts of the full year-end release that is published on Senzime's website: www.senzime.com.